Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Nov 20, 2026
TickeronGET DAILY SIGNALS
ECG vs MTZ: Pure-Play Contractor Meets Diversified Infrastructure Builder

ECG vs MTZ: Pure-Play Contractor Meets Diversified Infrastructure Builder

Key Takeaways

  • Both ECG and MTZ operate in U.S. infrastructure construction with meaningful exposure to data center, power grid, and energy demand, but they differ sharply in scale, diversification, and recent earnings momentum.
  • ECG, a pure-play electrical, mechanical, and transmission and distribution contractor, has reported accelerating revenue and net income growth alongside a backlog that nearly doubled year over year.
  • MTZ, a larger multi-segment infrastructure builder, has experienced a steeper recent drawdown in its share price relative to its 52-week high.
  • Tickeron AI Verdict: Based on observable trend consistency, earnings momentum, and backlog growth, Tickeron's AI would currently favor ECG over MTZ.
  • For deeper coverage of company developments and daily price action, explore ECG Major News, ECG Today's Price Move, MTZ Major News, and MTZ Today's Price Move.
  • To see the AI-selected trading strategies currently being highlighted for market conditions, explore Trending AI Robots.

Why Compare These Two Names Now

Investors following the U.S. infrastructure and construction space often weigh pure-play specialty contractors against larger, more diversified builders. ECG (Everus Construction Group) and MTZ (MasTec, Inc.) both stand to benefit from data center and electric grid expansion, yet they carry very different risk profiles. This comparison matters for traders assessing relative performance and for longer-term investors considering a focused high-growth contractor versus a broader infrastructure platform. Recent market pressure on both stocks makes a direct look at fundamentals, momentum, and sentiment especially relevant.

ECG: Strong Growth as a Focused Contractor

ECG, Everus Construction Group, works through two main segments: Electrical & Mechanical and Transmission & Distribution. After spinning off from MDU Resources late last year, it has emerged as a pure-play name tied to data center construction, power grid upgrades, and AI-related infrastructure needs. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry. Financial results for the first nine months of 2026 showed operating revenues up 33.6% year over year to about $3.65 billion, with net income rising roughly 59.8% to $234.1 million. Backlog reached $5.48 billion, nearly double the prior year’s $2.95 billion, while non-GAAP EBITDA margin improved to 9.8% from 8.6%.

The stock has still seen volatility. It has pulled back from a 52-week high near $171.58 and now trades in the low $80s, down more than 30% over three months with a sharp move lower in early November. Acquisitions such as SE&M and Epsilon for $295 million, along with a refinanced credit facility, have broadened its reach, though sector-wide swings have affected sentiment.

MTZ: Scale and Diversification Come with Volatility

MTZ, MasTec, Inc., is a larger infrastructure engineering and construction firm founded in 1929 and based in Coral Gables, Florida, with around 42,000 employees. It operates in five segments—Communications, Clean Energy and Infrastructure, Power Delivery, Pipeline Infrastructure, and Other—serving wireless providers, renewable developers, utilities, and pipeline operators. Trailing-twelve-month revenue is near $17.3 billion, highlighting its greater scale compared with ECG.

Recent price action has been weaker. MTZ has fallen from a 52-week high near $441.43 in May 2026 to the mid-$160s, a drop of roughly 40% over three months, with a beta near 1.92 indicating above-average volatility. Sell-side consensus remains a Strong Buy with an average price target near $301, suggesting analysts see the pullback as temporary relative to long-term backlog and demand. Higher leverage, with debt-to-equity above 100%, and sector profit-taking have contributed to the move lower.

Head-to-Head: Focus Versus Breadth

The main difference lies in concentration versus diversification. ECG offers direct exposure with a backlog that has nearly doubled and solid double-digit revenue growth, yet its smaller market capitalization of around $4.4 billion and narrower customer base leave it more exposed to any single project or market shift. MTZ spreads risk across five segments and a roughly $13–14 billion market cap but carries higher leverage and has seen a deeper price decline.

Both companies ride the same secular trends in data centers, grid modernization, and clean energy, though ECG is more tightly aligned with those themes. On the risk side, MTZ’s debt load and beta add financial and market sensitivity, while ECG’s concentration and shorter public track record bring their own uncertainties. Both stocks currently sit below longer-term moving averages, reflecting cautious sentiment across the sector.

Tickeron AI Verdict

Based on current observable factors, Tickeron’s AI would likely favor ECG over MTZ. The edge comes from more consistent fundamental momentum: accelerating revenue, expanding profitability, and a backlog that has nearly doubled year over year. These elements tend to support trend durability even in volatile periods. While MTZ enjoys strong analyst support and greater scale, its steeper drawdown, higher leverage, and less uniform earnings picture add comparatively more uncertainty. This view is probabilistic and draws from historical patterns; it is not a forecast of future returns.

Exploring AI-Driven Strategies

One tool I’ve found helpful for this kind of analysis is Tickeron’s AI Trading Bots. It lets me review automated strategies that align with current volatility and momentum conditions, adding a systematic layer to the fundamental review without replacing it.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: MTZ, ECG

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


MTZ in -17.26% downward trend, falling for three consecutive days on November 20, 2026

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where MTZ declined for three days, in 221 of 284 cases, the price declined further within the following month. The odds of a continued downward trend are 78%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 20, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MTZ as a result. In 57 of 76 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 75%.

The Moving Average Convergence Divergence Histogram (MACD) for MTZ turned negative on November 20, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In 37 of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at 74%.

The Aroon Indicator for MTZ entered a downward trend on November 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for MTZ's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

Following a +18.94% 3-day Advance, the price is estimated to grow further. Considering data from situations where MTZ advanced for three days, in 278 of 351 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.

MTZ may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 55 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 57 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.021) is normal, around the industry mean (15.143). P/E Ratio (27.461) is within average values for comparable stocks, (167.534). Projected Growth (PEG Ratio) (0.616) is also within normal values, averaging (3.522). Dividend Yield (0.000) settles around the average of (0.215) among similar stocks. P/S Ratio (1.103) is also within normal values, averaging (2.886).

The Tickeron Price Growth Rating for this company is 79 (best 1 - 100 worst), indicating slightly worse than average price growth. MTZ’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 83 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MTZ’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock worse than average.

The Tickeron PE Growth Rating for this company is 88 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

Notable companies

The most notable companies in this group are MasTec (NYSE:MTZ).

Industry description

Engineering & Construction includes companies that engage in non-residential construction and contract services, including ventilation, heating and air conditioning (HVAC) services. The level/value of construction & engineering activity is one of the potentially relevant indicators of the health of businesses, and hence of the overall economy. Some of the large-cap U.S. companies in this industry include Jacobs Engineering Group Inc,, AECOM and Quanta Services, Inc.

Market Cap

The average market capitalization across the Engineering & Construction Industry is 6.82B. The market cap for tickers in the group ranges from 69 to 2.15T. WKAPF holds the highest valuation in this group at 2.15T. The lowest valued company is WLGSF at 69.

High and low price notable news

The average weekly price growth across all stocks in the Engineering & Construction Industry was -9%. For the same Industry, the average monthly price growth was -10%, and the average quarterly price growth was -32%. PMA experienced the highest price growth at 19%, while FGL experienced the biggest fall at -52%.

Volume

The average weekly volume growth across all stocks in the Engineering & Construction Industry was -10%. For the same stocks of the Industry, the average monthly volume growth was 59% and the average quarterly volume growth was 46%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 48
P/E Growth Rating: 59
Price Growth Rating: 64
SMR Rating: 71
Profit Risk Rating: 78
Seasonality Score: -15 (-100 ... +100)
AI Screener 4
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a infrastructure construction company

Industry EngineeringConstruction

Industry
Engineering And Construction
Address
800 S. Douglas Road
Phone
+1 305 599-1800
Employees
36000
Web
https://www.mastec.com
Interact to see
Advertisement
SDD is an inverse leveraged ETF (exchange-traded fund) built to return roughly -2x the daily move of the S&P SmallCap 600 Index, making it a tactical hedging tool rather than a long-term holding. XXX is an asset-allocation ETF that blends roughly 75% S&P 500 large-cap equities with a 25% sleeve of XRP, a major cryptocurrency, aiming for capital appreciation.
AMD jumped +2.42%, rising $12.81 to $542.95 from Wednesday's close of $530.14, in early regular-session trading Thursday after extending gains built during premarket. The catalyst was Anthropic's IPO, priced at $83 a share above its marketed range and raising $81.3 billion in the largest listing on record; the debut revived sentiment across AI hardware names, and AMD is both an Anthropic supplier and a $2.5 billion investor in the lab.
ROM is an established, leveraged exchange-traded fund (ETF) that targets twice (2x) the daily return of the S&P Technology Select Sector Index, while XXX is a recently launched blended ETF pairing large-cap U.S. equities with XRP exposure. ROM benefits from deep liquidity and roughly $1.1 billion in AUM (assets under management); XXX remains far smaller, with assets measured in the hundreds of thousands of dollars.
NVIDIA (NVDA) has declined roughly 32.6% over the last 30 days, falling from $216.47 on October 20 to around $146 in mid-November trading. The selloff was triggered by the surprise resignation of founder and CEO Jensen Huang, along with governance, regulatory, and China-related concerns.
Micron shares slid from Thursday's $690.44 close to $635.41, a -7.97% loss, deepening during Friday's regular session after an already soft premarket. The decline was sector-driven, not company-specific: investors kept unwinding AI exposure as Anthropic fell back after its debut, while hawkish Fed comments and doubts about Nvidia's leadership and AI spending returns pressured chip valuations.